GlaxoSmithkline Consumer Healthcare is currently trading at Rs. 5032.00, down by 85.90 points or 1.68% from its previous closing of Rs. 5117.90 on the BSE.
The scrip opened at Rs. 5117.00 and has touched a high and low of Rs. 5143.90 and Rs. 5024.00 respectively.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 6584.20 on 25-Jul-2016 and a 52 week low of Rs. 4650.00 on 15-Nov-2016.
Last one week high and low of the scrip stood at Rs. 5150.30 and Rs. 5024.00 respectively. The current market cap of the company is Rs. 21,162.35 crore.
The promoters holding in the company stood at 72.46%, while Institutions and Non-Institutions held 12.77% and 14.77% respectively.
The company has reported 8.25% fall in its net profit at Rs 136.41 crore for third quarter ended December 31, 2016 as compared to Rs 148.68 crore for the same quarter in the previous year. Total income of the company decreased by 11.94% at Rs 1016.09 crore for the quarter under review as compared Rs 1153.86 crore for the corresponding quarter previous year.
GlaxoSmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks. It exports products to countries like Bangladesh, Myanmar, Sri Lanka, Middle East, Fiji, Mauritius, Nepal, Bhutan and many more.